GSK Launches UK Apprenticeship Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

GSK Launches UK Apprenticeship Program


ePT--the Electronic Newsletter of Pharmaceutical Technology

GlaxoSmithKline (GSK) is launching a new program that will create apprenticeships in several areas including manufacturing and R&D at the company’s United Kingdom sites. The scheme will commence in August and will offer 40 placements for young people (aged 16–24 years old) in the first intake.

Opportunities will be available in IT, R&D, manufacturing, supply chain management, and artwork design. The apprenticeships will be offered at nine sites: Barnard Castle, GSK House (London), Irvine, Maidenhead, Montrose, Slough, Ulverston, Ware, and Worthing. Depending on the discipline, the roles are expected to last between two and four years. Apprentices may be offered roles within the company at the end of the program.

According to a statement from GSK, the scheme will provide young people with hands-on experience in the life-sciences industry, as well as a base salary and a personalized training plan.

In the statement, John Hayes, the UK’s Skills Minister, said “The government has significantly increased investment in apprenticeships because we know they work for businesses and employees. The unique combination of high-quality training and meaningful work experience they offer helps to build a workforce with the skills our economy needs to grow. I am delighted that GSK are not only hiring new apprentices, but also expanding their program to cover a wide range of new disciplines.”

GSK has several programs in place to attract young talent. In 2011, the company revealed plans to reimburse 100% of uncapped university tuition fees for students recruited under its graduation scheme. This year, the company is also undertaking a ‘Scientists in Sport’ program in partnership with King’s College London (UK), which aims to showcase how science will be used during the upcoming 2012 London Olympic and Paralympic Games and inspire young people to choose scientific careers.

GSK currently employs approximately 15,000 people in the UK.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here